Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury
Authors:
- Ann K. DalyADAnn K. Daly
- Jill HendersonJHJill Henderson
- Julia GrahamJGJulia Graham
- Munir PirmohamedMPMunir Pirmohamed
- William BernalWBWilliam Bernal
- Christopher P. DayCDChristopher P. Day
- Guruprasad P. AithalGAGuruprasad P. Aithal
- 1 December 2010
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 53 (6) , 1049-1053
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillinNature Genetics, 2009
- Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United StatesGastroenterology, 2008
- Human leukocyte antigen polymorphisms in italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controlsHepatology, 2008
- Antibiotic therapy: a major cause of drug-induced jaundice in southwest EnglandEuropean Journal of Gastroenterology & Hepatology, 2007
- Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year PeriodGastroenterology, 2005
- Idiosyncratic drug hepatotoxicityNature Reviews Drug Discovery, 2005
- Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptideNature, 1994
- HLA DQA, DQB, and DRB genotyping by oligonucleotide analysis: distribution of alleles and haplotypes in British caucasoidsHuman Immunology, 1992
- Hepatic injury associated with the use of nitrofurans: A clinicopathological study of 52 reported casesHepatology, 1988
- HLA Antigens in Patients with Unexplained Hepatitis following Halothane AnesthesiaActa Anaesthesiologica Scandinavica, 1985